Among the numerous PON1 polymorphisms in humans, the Q192R and L55M polymorphisms are the ones most associated with lipoprotein oxidation and CHD risk, and there is evidence that these polymorphisms explain a significant proportion of the differences in PON1 activity between individuals [21]. Here, PON1 is linked to coronary artery disorder.